Liver architecture maintenance by tincture of Crataegus against isoproterenol-induced myocardially infarcted rats

Journal of Medicinal Food

Volumn 8, Issue 3, 2005, Pages 400-404

  Thirupurasundari, C J ^a   Jayalakshmi, R ^a   Devaraj, S Niranjali ^a,b  

^a UNIVERSITY OF MADRAS   (India)

^b Department of Biochemistry 9/2 ^*  (India)

Author keywords

Glycoproteins; Hepatoprotection; Marker enzymes; Tincture of crataegus

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; CARBOHYDRATE; CRATAEGUS EXTRACT; FUCOSE; HEXOSAMINE; HEXOSE; ISOPRENALINE; LACTATE DEHYDROGENASE; SIALIC ACID;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; CRATAEGUS; DRUG EFFECT; HEART INFARCTION; HEART PROTECTION; HISTOLOGY; LACTATE DEHYDROGENASE BLOOD LEVEL; LIVER DYSFUNCTION; LIVER INJURY; LIVER PROTECTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TINCTURE;

ALANINE TRANSAMINASE; ALKALINE PHOSPHATASE; ANIMALS; ASPARTATE AMINOTRANSFERASES; CRATAEGUS; FRUIT; ISOPROTERENOL; L-LACTATE DEHYDROGENASE; LIVER; LIVER DISEASES; MALE; MICE; MYOCARDIAL INFARCTION; PLANT EXTRACTS; RATS; RATS, WISTAR;

ANIMALIA; CRATAEGUS;

EID: 27144506541     PISSN: 1096620X     EISSN: None     Source Type: Journal    
DOI: 10.1089/jmf.2005.8.400     Document Type: Article

References (30)

1. rd ed. (Shearman DJC, Finlayson NDC, Camilleri M, eds.), Churchill Livingstone, New York, 1997, pp. 1097-1101.
2. Dunn GD, Hayes P, Breen KJ, Schenker S: The liver in congestive heart failure: A review. Am J Med Sci 1973;265:174-189.
3. Cohen JA, Kaplan MM: Left-sided heart failure presenting as hepatitis. Gastroenterology 1978;74:583-587.
4. Zimmerman HJ, Seeff LB: Enzymes in hepatic disease. In: Diagnostic Enzymology (Coodley EL, ed.), Lea and Febiger, Philadelphia, 1970, pp. 1-38.
5. Alan L, Miller ND: Botanical influences on cardiovascular disease. Altern Med Rev 1998;3:422-431.
6. Gabor M: Pharmacological effects of flavonoids on blood vessels. Angiologica 1972;9:355-374.
7. Ammon HPT, Handel M: Crataegu.s, toxicology and pharmacology. Part I: Toxicity. Planta Med 1981;43:105-120.
8. Shanthi S, Parasakthy K, Deepa Lakshmi PD, Niranjali Devaraj S: Hypolipidemic activity of tincture of Crataegus in rats. Indian J Biochem Biophys 1994;31:143-146.
9. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the Polin phenol reagent. J Biol Chem 1951; 193: 265-275.
10. Mohur AF, Coore IJY: Simple method of measuring serum level of glutamate oxaloacetate and glutamate pyruvate transaminase in routine laboratories. J Clin Pathol 1975;10:394-399.
11. King J: Lactate dehydrogenase. In: Practical Clinical Enzymology (Princeton HJ, ed.), Van Nostrand Reinhold Co. Ltd., London, 1965, pp. 83-93.
12. Kind PRN, King EJ: Estimation of plasma phosphatase by determination of hydrolysed phenol with amino ampyrine. J Clin Pathol 1954;7:322-330.
13. Neibes P: Determination of enzymes and degradation product of glycosaminoglycan metabolism in the serum of healthy and varicose subjects. Clin Chim Acta 1972;42:399-408.
14. Wagner WD: More sensitive assay discriminating galactosamine and glycosamine in mixture. Anal Biochem 1979;94:394-397.
15. Warren L: The thiobarbituric acid assay of sialic acids. J Biol Chem 1959;234:1971-1975.
16. Dische Z, Shettles LB: A specific colour reaction of methyl pentoses and a spectrophotometric micromethod for their determination. J Biol Chem 1948;175:595-603.
17. Slater TF: Free radical mechanisms in tissue injury. J Biochem (Tokyo) 1984;222:1-15.
18. Matloff DS, Selinger MJ, Kaplan MM: Hepatic transaminase activity in alcoholic liver diseases. Gastroenterology 1980;78: 1389-1392.
19. Flora KD, Keeffe EB: Evaluation of mildly abnormal liver tests in asymptomatic patients. J Insur Med 1990;22:264-267.
20. Hay JE. Czaja AJ. Rakela J. et al.: The nature of unexplained chronic aminotransferase elevations of a mild to moderate degree in asymptomatic patients. Hepatology 1989;9:193-197.
21. Clermont RJ, Chalmers TC: The transaminase tests in liver disease. Medicine 1967;46:197-207.
22. Rakotoarison DA. Gressier B. Trotin F. et al.: Antioxidant activities of polyphenolic extracts from flowers, in vitro callus and cell suspension cultures of Crataegus nwnogyna. Pharmazie 1997; 52:60-64.
23. Warnas TW: Alkaline phosphatase. Gut 1972;13:926-937.
24. Hatoff DE, Hardison WGM: Induced synthesis of alkaline phosphatase by bile acids in rat liver cell culture. Gastroenterology 1979;77:1062-1067.
25. Clement IP: Effect of partial hepatectomy and hydrocortisone administration on liver and serum sialyl transferase activities. Biochim Biophys Acta 1979;583:14-19.
26. Gottschalk A: Correlation between composition, structure, shape and function of a salivary mucoprotein. Nature 1960;186: 949-951.
27. Alpers DH, Isselbacher KJ: The effect of carbon tetrachloride on rat-liver lysosomes. Biochim Biophys Acta 1967:137:33-42.
28. Sherlock S: The liver in heart failure. Relation to anatomical, functional and circulatory changes. Br Heart J 1951;13:273-293.
29. Kanel GC, Ucci AA. Kaplan MM. et al.: A distinctive perivenular hepatic lesion associated with heart failure. Am J Clin Pathol 1980;73:235-239.
30. Lefkowitch JH. Mendez L: Morphologic features of hepatic injury in cardiac disease and shock. J Hepatol 1986;2:313-327.